The invention provides a method for the preparation of bone-polymer composites wherein the mineral portion of the bone is treated with a coupling agent before being incorporated into a biocompatible polymeric matrix. The resulting composites may be used as such or be further processed to form an ost
The invention provides a method for the preparation of bone-polymer composites wherein the mineral portion of the bone is treated with a coupling agent before being incorporated into a biocompatible polymeric matrix. The resulting composites may be used as such or be further processed to form an osteoimplant.
대표청구항▼
What is claimed is: 1. A composite, comprising: a plurality of bone particles and a biocompatible polymer, wherein at least a portion of the bone particles are covalently linked to the polymer through a silane coupling agent, wherein the bone particles represent about 60% to about 75% of the total
What is claimed is: 1. A composite, comprising: a plurality of bone particles and a biocompatible polymer, wherein at least a portion of the bone particles are covalently linked to the polymer through a silane coupling agent, wherein the bone particles represent about 60% to about 75% of the total weight of the composite. 2. A composite comprising: a plurality of bone particles; and a biocompatible polymer; wherein at least a portion of the bone particles are covalently linked to the polymer through a silane coupling agent; and wherein the polymer is selected from the group consisting of polysaccharides. 3. The composite of claim 2, wherein the polymer is selected from the group consisting of starch, dextran, cellulose, gelatin, collagen, and derivatives thereof. 4. The composite comprising: a plurality of bone particles; a biocompatible polymer; and a cross-linking agent; wherein at least a portion of the bone particles are covalently linked to the polymer through a silane coupling agent; and wherein the cross-linking agent is selected from the group consisting of aldehydes, polyepoxy compounds, polyvalent metallic oxides, organic tannins, N-hydroxysuccinimides, N-hydroxysulfosuccinimides, phenolic oxides, hydrazides, carbodiimides, isocyanates, isothiocyanates, sugars, and enzymes. 5. The composite of claim 1, 2, or 4, wherein the bone particles are obtained from one or more of autologous bone, allogenic bone, xenogenic bone, or mixtures thereof. 6. The composite of claim 1, 2, or 4, wherein the bone particles are obtained from one or more of cortical bone, cancellous bone, cortico-cancellous bone, or mixtures thereof. 7. The composite of claim 1, 2, or 4, wherein the bone particles are obtained from one or more of nondemineralized bone, deorganified bone, anorganic bone, or mixtures thereof. 8. The composite of claim 2 or 4, wherein the bone particles represent about 60% to about 75% of the total weigh of the composite. 9. The composite of claim 1, 2, or 4, wherein the coupling agent is a silane selected from the group consisting of silanes bearing one hydrolyzable or leaving group, silanes bearing two hydrolyzable or leaving groups, and silanes bearing three hydrolyzable or leaving groups. 10. The composite of claim 1, 2, or 4, wherein the polymer is a biocompatible polymer selected from the group consisting of polymers of natural origin, polymers of artificial origin, and any combination of natural and artificial polymers. 11. The composite of claim 1, 2, or 4, wherein the polymer is a selected from the group consisting of biodegradable polymers, non-biodegradable polymers, co-polymers of biodegradable polymers, co-polymers of non-biodegradable polymers, and co-polymers of biodegradable and non-biodegradable polymers. 12. The composite of claim 1 or 4, wherein the polymer is a natural polymer selected from the group consisting of polysaccharides. 13. The composite of claim 8, wherein the polymer is selected from the group consisting starch, dextran, cellulose, gelatin, collagen, and derivatives thereof. 14. The composite of claim 1 or 4, wherein the polymer is an artificial polymer selected from the group consisting of poly(anhydrides), poly(hydroxy acids), polyesters, poly(orthoesters), polycarbonates, poly(propylene fumerates), poly(caprolactones), polyamides, polyamino acids, polyacetals, polylactides, polyglycolides, poly(dioxanones), polysulfones, polyhydroxybutyrates, polyhydroxyvalyrates, poly(vinyl pyrrolidone), biodegradable polycyanoacrylates, biodegradable polyurethanes, polysaccharides, tyrosine-based polymers, poly(methyl vinyl ether), poly(maleic anhydride), poly(glyconates), polyphosphazines, poly(esteramides), polyketals, poly(orthocarbonates), poly(maleic acid), poly(alkylene oxalates), poly(alkylene succinates), poly(pyrrole), poly(aniline), poly(thiophene), polystyrene, non-biodegradable polyurethanes, polyureas, poly(ethylene vinyl acetate), polypropylene, polymethacrylate, polyethylene, poly(ethylene oxide), and co-polymers, adducts, and mixtures thereof. 15. The composite of claim 1, 2, or 4, wherein a surface of at least a portion of the bone particles has been chemically modified. 16. The composite of claim 15, wherein the surface of at least a portion of the bone particles is treated with dilute phosphoric acid. 17. The composite of claim 1, 2, or 4, wherein the composition of the bone particle has been modified. 18. The composition of claim 17, wherein at least a portion of the bone particles are dried, lyophilized, defatted, treated with a detergent, treated with a solvent, treated with a surfactant, or treated to remove or inactivate pathogens. 19. The composite of claim 1 or 2, further comprising a cross-linking agent. 20. The composite of claim 19, wherein the cross-linking agent is selected from the group consisting of aldehydes, polyepoxy compounds, polyvalent metallic oxides, organic tannins, N-hydroxysuccinimides, N-hydroxysulfosuccinimides, phenolic oxides, hydrazides, carbodiimides, isocyanates, isothiocyanates, sugars and enzymes. 21. The composite of claim 1, 2, or 4, further comprising one or more of a wetting agent, biocompatible binder, filler, fiber, plasticizer, biostatic/biocidal agent, surface active agent, biomolecule, small molecule, or bioactive agent. 22. The composite of claim 21, wherein the bioactive agent is selected from the group consisting of antibiotics, chemotherapeutics, bone cell inducers, and bone cell stimulators. 23. The composite of claim 1, 2, or 4, further comprising osteoblasts. 24. The composite of claim 21, wherein the bioactive agent is selected from the group consisting of bone morphogenic proteins (BMPs), transforming growth factor-beta (TGF-β), insulin-like growth factor, platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), parathyroid hormone (PTH), growth factor binding proteins, and angiogenic factor.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable polymer composition.
Vacanti Joseph P. ; Vacanti Charles A. ; Langer Robert S., Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous struct.
Deibig Heinrich (Frankfurt am Main Schwalbach DEX) Heide Helmut (Schwalbach DEX) Reiner Roland (Eschborn DEX) Koster Kari (Lorsbach DEX), Bone replacement or prosthesis anchoring material.
Marcolongo Michele S. (Lansdowne PA) Ducheyne Paul (Rosemont PA) Ko Frank (Philadelphia PA) LaCourse William (Alfred NY), Composite materials using bone bioactive glass and ceramic fibers.
Katti Kattesh V. ; Berning Douglas E. ; Volkert Wynn A. ; Ketring Alan R. ; Churchill Robert, Conjugate and method for forming aminomethyl phosphorus conjugates.
Schulman Joseph H. ; Byers Charles L. ; Adomian Gerald E. ; Colvin Michael S., Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces.
Kennedy Alvin P. (Midland MI) Bratton Larry D. (Lake Jackson TX) Jezie Zdravko (Lake Jackson TX) Lane Eckel R. (Midland MI) Perettie Donald J. (Midland MI) Richey W. Frank (Lake Jackson TX) Babb Davi, Laminates of polymers having perfluorocyclobutane rings and polymers containing perfluorocyclobutane rings.
Kretschmann Josef (Langenfeld DEX) Ritter Wolfgang (Haan DEX) Fues Johann-Friedrich (Grevenbroich DEX), New materials for bone replacement and for joining bones or prostheses.
Powers Kenneth W. (Berkeley Heights NJ) Wang Hsien-Chang (Edison NJ) Chung T-C (State College PA) Dias Anthony J. (Linden NJ) Olkusz Joseph A. (Fanwood NJ), Para-alkylstyrene/isoolefin copolymers and functionalized copolymers thereof.
Scarborough Nelson L. ; Morris John W. ; Russell James L. ; Dowd Michael, Pressure flow system and method for treating a fluid permeable workpiece such as a bone.
Daniels John R. (Menlo Park CA) Knapp Terry R. (Santa Clara CA), Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution.
Fages Jacques,FRX ; Marty Alain,FRX ; Combes Didier,FRX ; Condoret Jean-Stephane,FRX, Process for treating bone tissue and corresponding implantable biomaterials.
Perez, Jesus Manuel; Kaittanis, Charalambos; Asati, Atul; Santra, Santimukul, Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation.
Rusin, Richard P.; Mitra, Sumita B.; Cummings, Kevin M., Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof.
Sakamoto, Jeff S.; Weiss, James R.; Fleurial, Jean-Pierre; Kisor, Adam; Tuszynski, Mark; Stokols, Shula; Holt, Todd Edward; Welker, David James; Breckon, Christopher David, High aspect ratio template and method for producing same.
Sakamoto, Jeff S.; Tuszynski, Mark Henry; Gros, Thomas; Chan, Christina; Mehrotra, Sumit, High aspect ratio template and method for producing same for central and peripheral nerve repair.
Lin, Jo-Wen; Martz, Erik O.; Millets, Joel F.; Rosenthal, Daniel; Chow, David, Implant frames for use with settable materials and related methods of use.
Seal, Sudipta; Karakoti, Ajay; Shridhar, Vijayalakshmi; Giri, Shailendra, Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide.
Crudden, Joseph J.; Hafiz, Jami; Deaton, James E.; Pepper, John R.; Johns, Derrick, Method of manufacturing antimicrobial implants of polyetheretherketone.
Crudden, Joseph J.; Hafiz, Jami; Deaton, James E.; Pepper, John R.; Johns, Derrick, Method of manufacturing antimicrobial implants of polyetheretherketone.
Bezwada, Rao; Darr, Aniq; Kronenthal, Richard L.; Pacifico, John, Multi-putty adhesive and cement compositions for tissue hemostasis, repair and reconstruction.
Seal, Sudipta; Das, Soumen; Cimini, Annamaria; D'Angelo, Barbara, Nanoparticles of cerium oxide targeted to an amyloid beta antigen of alzheimer's disease and associated methods.
Cimini, Annamaria; D'Angelo, Barbara; Das, Soumen; Seal, Sudipta, Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.